Would you like to participate in a clinical research study for people with Atopic Dermatitis?

We’re inviting you to take part in a study for adults who have Atopic Dermatitis to evaluate the effect of an investigational medication for moderate to severe Atopic Dermatitis.

All study-related visits, tests, and investigational medication or placebo will be provided at no cost. In addition, reimbursement for study-related travel may be provided.

The ADopt-VA Atopic Dermatitis Study is evaluating an investigational medication for the treatment of moderate to severe Eczema.

You may pre-qualify for the ADopt-VA Atopic Dermatitis Study if you:

  • Are 18 to 55 years old
  • Have had Atopic Dermatitis/Eczema for at least one year
  • Have used another Eczema treatment or cream that did not fully treat your Eczema

All study-related care is provided by a dedicated Medical Team.

VOLUNTEERS WHO QUALIFY TO TAKE PART IN THE STUDY MAY RECEIVE REIMBURSEMENT FOR STUDY-RELATED TRAVEL.
Participate
Participate
Participate

About Atopic Dermatitis

Atopic Dermatitis (AD) is a complex disease that is determined by genetic, environmental and immunologic factors.1 AD is one of the most common chronic medical diseases, 2--10% of adults are affected, and the prevalence appears to have increased over the past two to three decades.2

The condition causes chronic itchy, red skin that flares up. Often, this condition is associated with allergies, hay fever or asthma.3

Although people may experience their Atopic Dermatitis symptoms differently, common symptoms include:4

  • Dry skin
  • Itchy spots on the skin
  • Oozing, weeping rashes
  • Thickened or crusty skin
  • Discoloration of the skin
  • Raw or sensitive skin

There is no cure for Atopic Dermatitis. There are certain lifestyle changes that can be made to avoid flare-ups or medications to soothe symptoms.

The purpose of the ADopt-VA Atopic Dermatitis Study is to evaluate the immune response to common vaccines during treatment with an investigational medication for Eczema.

References:

Frequently Asked Questions

What is a clinical research study?

A clinical research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved for clinical use and prescribed to patients.

We are looking for volunteers 18 to 55 years of age, who have moderate to severe Atopic Dermatitis, to participate in the ADopt-VA Atopic Dermatitis Study. The goal of the study is to evaluate the immune response to vaccinations for participants receiving the investigational medication. They want to compare the investigational drug to a placebo, which looks like the investigational drug, but contains no active ingredients. Participating in this study does not disqualify you from receiving the COVID-19 vaccine, nor does it require you to receive it. The COVID-19 vaccine is not being studied in this clinical trial.

Individuals will be evaluated to determine their eligibility to participate. Those who qualify may receive either the investigational medication or a placebo, as well as study-related medical exams and laboratory tests, all at no cost. Reimbursement for travel may also be available.

Participation in the ADopt-VA Atopic Dermatitis Study will last approximately 30 weeks, and consists of three parts:

  • During a screening period of up to 30 days, the study doctor will perform tests and procedures to determine if you are eligible to participate.
  • If eligible, you will enter the study. You will then be randomly assigned to receive the investigational medication, or to receive a placebo (which contains no active medication). The investigational medication and the placebo are both delivered as injections. The treatment period will last approximately 16 weeks. You will also receive two common approved vaccines as part of your study participation. The study doctor will explain all study requirements and length of participation in greater detail during the screening period.
  • You may stop participating by scheduling a safety follow-up visit approximately 12 weeks after the last dose of investigational medication. Or, if at the end of the treatment period you meet certain criteria, you may be eligible to continue receiving the investigational medication in a separate long-term extension study.

In this study, participants will be randomly assigned to receive either the investigational medication or a placebo, and neither the participants nor the study team will know the treatment assignment, but in case of an emergency, the study doctor can quickly find out.

Volunteers who qualify to take part in the study may receive payment to reimburse you for transportation or parking payments related to visiting the study center. Please discuss this with the study team when they contact you.

There is no cost to participate in the ADopt-VA Atopic Dermatitis Study. Those who qualify may receive either the investigational medication or a placebo, as well as study-related medical exams and laboratory tests, all at no cost.
If you decide to take part:

  • You will receive study-related care throughout the study from a team of experienced study doctors and nurses.
  • Those who qualify may receive either the investigational medication or a placebo, as well as study-related medical exams and laboratory tests, all at no cost.

The research team will be able to explain more about what the ADopt-VA Atopic Dermatitis Study will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.

We match you to a study site within a close travel distance from your home. If we are not running a study in your area currently, with your permission, we will keep you in our database and reach out if a study in your area becomes available. If, at any time, you decided you no longer want your information stored, you can opt out and we will delete your details.

About the ADopt-VA Atopic Dermatitis Study

The ADopt-VA Atopic Dermatitis Study will take place in study sites in the United States, with about 240 people with moderate to severe Atopic Dermatitis participating.

Participants will receive all study-related visits, tests, and study drug from a dedicated medical team at no cost.

Your participation in this study will last for up to approximately 30 weeks, and you may need to come to the study center at least 5 times during this period. The study doctor will explain all study requirements and length of participation in greater detail during the screening period.

Volunteers who qualify to take part in the study may receive reimbursement for study-related travel.

You may pre-qualify for the ADopt-VA Atopic Dermatitis Study if you:

  • Are 18 to 55 years old
  • Have had Atopic Dermatitis/Eczema for at least one year
  • Have used another Eczema treatment or cream that did not fully treat your Eczema

All study-related care is provided by a dedicated Medical Team.

In this study, researchers will be evaluating the immune response to common vaccines during treatment with an investigational medication for Eczema. Participating in this study does not disqualify you from receiving the COVID-19 vaccine, nor does it require you to receive it. The COVID-19 vaccine is not being studied in this clinical trial.

Sign Up

What happens if I sign up? We will match you to a study location in your area that needs volunteers with Atopic Dermatitis, or we will notify you when one becomes available. The study team will then contact you, and you may have the opportunity to participate if qualified.


If you think you might like to participate in the ADopt-VA Atopic Dermatitis Study or would like more information, please enter your information below so that we can contact you and see if you may qualify to join a study. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.